Rank | Gene Set | Z-score |
---|---|---|
1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.05891299 |
2 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.96375464 |
3 | negative regulation of cell killing (GO:0031342) | 5.96375464 |
4 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.86162153 |
5 | modulation by symbiont of host immune response (GO:0052553) | 5.86162153 |
6 | positive regulation by symbiont of host defense response (GO:0052509) | 5.86162153 |
7 | modulation by symbiont of host defense response (GO:0052031) | 5.86162153 |
8 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.86162153 |
9 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.86162153 |
10 | detection of molecule of bacterial origin (GO:0032490) | 5.83543793 |
11 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.61627725 |
12 | axon ensheathment in central nervous system (GO:0032291) | 5.35952920 |
13 | central nervous system myelination (GO:0022010) | 5.35952920 |
14 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 5.29346266 |
15 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.24375488 |
16 | detection of other organism (GO:0098543) | 5.21683323 |
17 | microglial cell activation (GO:0001774) | 4.99824118 |
18 | detection of external biotic stimulus (GO:0098581) | 4.97784018 |
19 | neutrophil activation involved in immune response (GO:0002283) | 4.92544418 |
20 | macrophage activation involved in immune response (GO:0002281) | 4.84865325 |
21 | cellular extravasation (GO:0045123) | 4.76225470 |
22 | negative regulation of neurotransmitter secretion (GO:0046929) | 4.61261127 |
23 | detection of bacterium (GO:0016045) | 4.55414822 |
24 | response to peptidoglycan (GO:0032494) | 4.49352608 |
25 | neutrophil mediated immunity (GO:0002446) | 4.41307652 |
26 | detection of biotic stimulus (GO:0009595) | 4.36188201 |
27 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.35120087 |
28 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.33106270 |
29 | eye photoreceptor cell differentiation (GO:0001754) | 4.28658612 |
30 | photoreceptor cell differentiation (GO:0046530) | 4.28658612 |
31 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.23841001 |
32 | response to host immune response (GO:0052572) | 4.23841001 |
33 | macrophage activation (GO:0042116) | 4.23779516 |
34 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.20969168 |
35 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.16778395 |
36 | rhodopsin mediated signaling pathway (GO:0016056) | 4.09221167 |
37 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 4.08181429 |
38 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 4.01215733 |
39 | regulation of gamma-delta T cell activation (GO:0046643) | 4.01070788 |
40 | negative regulation of interleukin-12 production (GO:0032695) | 3.98731209 |
41 | neutrophil activation (GO:0042119) | 3.97863978 |
42 | axon ensheathment (GO:0008366) | 3.90911855 |
43 | ensheathment of neurons (GO:0007272) | 3.90911855 |
44 | myeloid leukocyte mediated immunity (GO:0002444) | 3.87354843 |
45 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.86573918 |
46 | myelination (GO:0042552) | 3.86415626 |
47 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 3.86000395 |
48 | myelin maintenance (GO:0043217) | 3.85684313 |
49 | apical protein localization (GO:0045176) | 3.84229371 |
50 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.83136102 |
51 | response to host (GO:0075136) | 3.83136102 |
52 | response to host defenses (GO:0052200) | 3.83136102 |
53 | negative regulation of neurotransmitter transport (GO:0051589) | 3.78451574 |
54 | asymmetric protein localization (GO:0008105) | 3.75926037 |
55 | respiratory burst (GO:0045730) | 3.75497366 |
56 | leukocyte aggregation (GO:0070486) | 3.72687329 |
57 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.71042526 |
58 | retinal rod cell development (GO:0046548) | 3.66337241 |
59 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.66001252 |
60 | myeloid cell activation involved in immune response (GO:0002275) | 3.63373676 |
61 | response to interleukin-15 (GO:0070672) | 3.63098338 |
62 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.62544333 |
63 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.60044506 |
64 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.59324433 |
65 | detection of light stimulus involved in visual perception (GO:0050908) | 3.56103652 |
66 | detection of light stimulus involved in sensory perception (GO:0050962) | 3.56103652 |
67 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.55928401 |
68 | presynaptic membrane assembly (GO:0097105) | 3.55038395 |
69 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.50249314 |
70 | granulocyte activation (GO:0036230) | 3.50135926 |
71 | cellular potassium ion homeostasis (GO:0030007) | 3.49860761 |
72 | negative regulation of T cell mediated immunity (GO:0002710) | 3.46547422 |
73 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.45141773 |
74 | cellular response to interleukin-15 (GO:0071350) | 3.44503006 |
75 | presynaptic membrane organization (GO:0097090) | 3.43499464 |
76 | virion attachment to host cell (GO:0019062) | 3.42143348 |
77 | adhesion of symbiont to host cell (GO:0044650) | 3.42143348 |
78 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.40517413 |
79 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.31671440 |
80 | immunoglobulin mediated immune response (GO:0016064) | 3.27516822 |
81 | synaptic vesicle maturation (GO:0016188) | 3.26702169 |
82 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 3.26679399 |
83 | B cell receptor signaling pathway (GO:0050853) | 3.26308332 |
84 | negative regulation of B cell mediated immunity (GO:0002713) | 3.24203076 |
85 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 3.24203076 |
86 | photoreceptor cell maintenance (GO:0045494) | 3.23545475 |
87 | positive regulation of mast cell activation (GO:0033005) | 3.21136139 |
88 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.20957383 |
89 | dendritic cell migration (GO:0036336) | 3.20915408 |
90 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 3.14100512 |
91 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.13090068 |
92 | regulation of tolerance induction (GO:0002643) | 3.11400780 |
93 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.09585089 |
94 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.07790349 |
95 | regulation of synaptic vesicle transport (GO:1902803) | 3.06669520 |
96 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.06555118 |
97 | regulation of mast cell activation (GO:0033003) | 3.05800010 |
98 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.05575960 |
99 | synaptic vesicle endocytosis (GO:0048488) | 3.05396227 |
100 | regulation of mast cell degranulation (GO:0043304) | 3.05052978 |
101 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.03083965 |
102 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.03083965 |
103 | synaptic vesicle exocytosis (GO:0016079) | 3.02032468 |
104 | neuron cell-cell adhesion (GO:0007158) | 3.00287612 |
105 | regulation of macrophage cytokine production (GO:0010935) | 3.00002345 |
106 | fatty acid elongation (GO:0030497) | 2.99695208 |
107 | nerve growth factor signaling pathway (GO:0038180) | 2.98805298 |
108 | mating behavior (GO:0007617) | 2.98707118 |
109 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.98367884 |
110 | glycerophospholipid catabolic process (GO:0046475) | 2.95410137 |
111 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.94879427 |
112 | leukocyte degranulation (GO:0043299) | 2.93734378 |
113 | retinal cone cell development (GO:0046549) | 2.93482226 |
114 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.92862703 |
115 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.91665213 |
116 | positive regulation of tolerance induction (GO:0002645) | 2.89579138 |
117 | myeloid leukocyte activation (GO:0002274) | 2.89528746 |
118 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.89218822 |
119 | photoreceptor cell development (GO:0042461) | 2.88987920 |
120 | negative regulation of adaptive immune response (GO:0002820) | 2.88123646 |
121 | positive regulation of macrophage cytokine production (GO:0060907) | 2.88044823 |
122 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.86929261 |
123 | regulation of B cell differentiation (GO:0045577) | 2.85866296 |
124 | dendritic cell chemotaxis (GO:0002407) | 2.83139508 |
125 | T-helper 1 type immune response (GO:0042088) | 2.82769743 |
126 | eye photoreceptor cell development (GO:0042462) | 2.82217842 |
127 | oligodendrocyte differentiation (GO:0048709) | 2.81927375 |
128 | response to redox state (GO:0051775) | 2.81689851 |
129 | regulation of interleukin-6 biosynthetic process (GO:0045408) | 2.80375985 |
130 | neutrophil chemotaxis (GO:0030593) | 2.78642944 |
131 | potassium ion homeostasis (GO:0055075) | 2.78392015 |
132 | response to lipoprotein particle (GO:0055094) | 2.77866081 |
133 | long-chain fatty acid biosynthetic process (GO:0042759) | 2.77284524 |
134 | negative T cell selection (GO:0043383) | 2.76310430 |
135 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.75814706 |
136 | defense response to protozoan (GO:0042832) | 2.75045227 |
137 | positive regulation of interferon-alpha production (GO:0032727) | 2.74930204 |
138 | regulation of collateral sprouting (GO:0048670) | 2.74658028 |
139 | negative thymic T cell selection (GO:0045060) | 2.74322494 |
140 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.74177899 |
141 | positive regulation of B cell differentiation (GO:0045579) | 2.74042228 |
142 | negative regulation of interleukin-17 production (GO:0032700) | 2.73445911 |
143 | neutrophil migration (GO:1990266) | 2.73436453 |
144 | protein localization to synapse (GO:0035418) | 2.72123757 |
145 | adult walking behavior (GO:0007628) | 2.71248878 |
146 | macroautophagy (GO:0016236) | 2.70936418 |
147 | glutamate secretion (GO:0014047) | 2.70187834 |
148 | regulation of leukocyte degranulation (GO:0043300) | 2.69618497 |
149 | positive thymic T cell selection (GO:0045059) | 2.69167533 |
150 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 2.68856914 |
151 | response to muramyl dipeptide (GO:0032495) | 2.68833896 |
152 | locomotory exploration behavior (GO:0035641) | 2.68781717 |
153 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.68514599 |
154 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.68404466 |
155 | L-serine transport (GO:0015825) | 2.67170529 |
156 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.65418424 |
157 | regulation of beta-amyloid formation (GO:1902003) | 2.64614417 |
158 | transmission of nerve impulse (GO:0019226) | 2.62850305 |
159 | cerebellar granule cell differentiation (GO:0021707) | 2.62655631 |
160 | regulation of ARF protein signal transduction (GO:0032012) | 2.59566294 |
161 | adhesion of symbiont to host (GO:0044406) | 2.57254698 |
162 | phosphatidylinositol dephosphorylation (GO:0046856) | 2.56675442 |
163 | membrane hyperpolarization (GO:0060081) | 2.56628406 |
164 | phospholipid translocation (GO:0045332) | 2.55504306 |
165 | lipid translocation (GO:0034204) | 2.55504306 |
166 | vesicle transport along microtubule (GO:0047496) | 2.55152862 |
167 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.53890828 |
168 | piRNA metabolic process (GO:0034587) | 2.53366803 |
169 | L-amino acid import (GO:0043092) | 2.51635718 |
170 | Leydig cell differentiation (GO:0033327) | 2.50129761 |
171 | long-term synaptic potentiation (GO:0060291) | 2.49425988 |
172 | protein localization to endosome (GO:0036010) | 2.48265209 |
173 | cyclic nucleotide catabolic process (GO:0009214) | 2.45807303 |
174 | cellular response to catecholamine stimulus (GO:0071870) | 2.43437557 |
175 | cellular response to monoamine stimulus (GO:0071868) | 2.43437557 |
176 | Golgi to endosome transport (GO:0006895) | 2.42400928 |
177 | regulation of neurotransmitter secretion (GO:0046928) | 2.42292081 |
178 | protein palmitoylation (GO:0018345) | 2.40272138 |
179 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.39720904 |
180 | negative regulation of inclusion body assembly (GO:0090084) | 2.38339897 |
181 | positive regulation of potassium ion transport (GO:0043268) | 2.37390824 |
182 | potassium ion import (GO:0010107) | 2.37327587 |
183 | neuron-neuron synaptic transmission (GO:0007270) | 2.37185563 |
184 | astrocyte development (GO:0014002) | 2.35915123 |
185 | striatum development (GO:0021756) | 2.33703714 |
186 | serine transport (GO:0032329) | 2.33135821 |
187 | protein targeting to Golgi (GO:0000042) | 2.32925876 |
188 | phospholipid dephosphorylation (GO:0046839) | 2.32209745 |
189 | negative regulation of exocytosis (GO:0045920) | 2.31702777 |
190 | negative regulation of synaptic transmission (GO:0050805) | 2.31432355 |
191 | early endosome to late endosome transport (GO:0045022) | 2.30880962 |
192 | activated T cell proliferation (GO:0050798) | 2.30685341 |
193 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.30357256 |
194 | positive regulation of membrane potential (GO:0045838) | 2.29758241 |
195 | neuronal action potential propagation (GO:0019227) | 2.29536766 |
196 | response to pheromone (GO:0019236) | 2.29317523 |
197 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.29071464 |
198 | neuron remodeling (GO:0016322) | 2.27148850 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.75694669 |
2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.67901928 |
3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.83883680 |
4 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.61047805 |
5 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.36724088 |
6 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.10520274 |
7 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.01355887 |
8 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.97199640 |
9 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.74658600 |
10 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.70138045 |
11 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.70004489 |
12 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.66940461 |
13 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.65613193 |
14 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.64625031 |
15 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.51698157 |
16 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.45979813 |
17 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.41107735 |
18 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.33632925 |
19 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.25429559 |
20 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.25037239 |
21 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 2.20336758 |
22 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 2.20171073 |
23 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.18240678 |
24 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.15548189 |
25 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.03298796 |
26 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.99693358 |
27 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.98730107 |
28 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.97489120 |
29 | MYB_26560356_Chip-Seq_TH2_Human | 1.95367747 |
30 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.90341479 |
31 | SPI1_23127762_ChIP-Seq_K562_Human | 1.89118649 |
32 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.88114638 |
33 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.84519876 |
34 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.82109116 |
35 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.79906884 |
36 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.79702542 |
37 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.78477731 |
38 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.77690242 |
39 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.74103398 |
40 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.72302468 |
41 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.71059529 |
42 | STAT3_23295773_ChIP-Seq_U87_Human | 1.69556072 |
43 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.68312643 |
44 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.66999372 |
45 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.65629229 |
46 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.61258988 |
47 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.61247559 |
48 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.58275535 |
49 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.57183540 |
50 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.57167914 |
51 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.56980880 |
52 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.54897622 |
53 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.53885188 |
54 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.52154572 |
55 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.51765813 |
56 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.51726645 |
57 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.50764051 |
58 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.50622839 |
59 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.48772941 |
60 | FUS_26573619_Chip-Seq_HEK293_Human | 1.48210435 |
61 | TCF4_23295773_ChIP-Seq_U87_Human | 1.47204278 |
62 | MYB_26560356_Chip-Seq_TH1_Human | 1.44620429 |
63 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.44461744 |
64 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.42876212 |
65 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.42545093 |
66 | GATA3_26560356_Chip-Seq_TH2_Human | 1.41255040 |
67 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.41141371 |
68 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.40978061 |
69 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.39786599 |
70 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.39637737 |
71 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.38596986 |
72 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.38397935 |
73 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.37862773 |
74 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.37655078 |
75 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.37574570 |
76 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.37179900 |
77 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.36569354 |
78 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.35847069 |
79 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.35328057 |
80 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.34425588 |
81 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.33662684 |
82 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.33412979 |
83 | * RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.32778015 |
84 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.32516649 |
85 | TP53_16413492_ChIP-PET_HCT116_Human | 1.30748622 |
86 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.30588784 |
87 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.28906684 |
88 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.28425553 |
89 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.28306507 |
90 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.28286843 |
91 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.28286843 |
92 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.27546450 |
93 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.26824060 |
94 | VDR_22108803_ChIP-Seq_LS180_Human | 1.26572408 |
95 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.26041021 |
96 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.25106543 |
97 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.24145570 |
98 | AR_25329375_ChIP-Seq_VCAP_Human | 1.23146805 |
99 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.22275360 |
100 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.21765902 |
101 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.20437032 |
102 | GATA1_22025678_ChIP-Seq_K562_Human | 1.19940474 |
103 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.19567514 |
104 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.18412022 |
105 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.17735386 |
106 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.17000723 |
107 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.15720811 |
108 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.14322864 |
109 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.14251441 |
110 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.12866120 |
111 | * CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.12498916 |
112 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.12043697 |
113 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.11536426 |
114 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.09382283 |
115 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.08426232 |
116 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.07879177 |
117 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.07669457 |
118 | KDM2B_26808549_Chip-Seq_REH_Human | 1.07550422 |
119 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.07287634 |
120 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.06883597 |
121 | MAF_26560356_Chip-Seq_TH1_Human | 1.06065630 |
122 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.05280069 |
123 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.05248691 |
124 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.05231963 |
125 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.05157471 |
126 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.03528925 |
127 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.03332171 |
128 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.03023454 |
129 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.02946218 |
130 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.02939062 |
131 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.02751606 |
132 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.02705421 |
133 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.02629283 |
134 | AR_19668381_ChIP-Seq_PC3_Human | 1.02482930 |
135 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.02315004 |
136 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.02064345 |
137 | * TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.01977435 |
138 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.01450959 |
139 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.00948784 |
140 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.00734017 |
141 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.00631805 |
142 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.00190289 |
143 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.00126676 |
144 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.00126676 |
145 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.99914702 |
146 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.99800660 |
147 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.99691103 |
148 | TBL1_22424771_ChIP-Seq_293T_Human | 0.99144279 |
149 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.98154027 |
150 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.97139986 |
151 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.96965471 |
152 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.96151851 |
153 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.94277553 |
154 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.94136520 |
155 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.93089360 |
156 | * SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.91461015 |
157 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.90457933 |
158 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.90441960 |
159 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.90394719 |
160 | * UTX_26944678_Chip-Seq_JUKART_Human | 0.90110354 |
161 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.88586010 |
162 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.87830601 |
163 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.86552242 |
164 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.85126234 |
165 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.83530051 |
166 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.81027375 |
167 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.80209268 |
168 | * GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.78224213 |
169 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.77953108 |
170 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.76734743 |
171 | GATA2_19941826_ChIP-Seq_K562_Human | 0.75984657 |
172 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.75776192 |
173 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.74887433 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003724_increased_susceptibility_to | 6.51017556 |
2 | MP0005551_abnormal_eye_electrophysiolog | 4.41144665 |
3 | MP0003880_abnormal_central_pattern | 3.52762898 |
4 | MP0000920_abnormal_myelination | 3.49965027 |
5 | MP0003436_decreased_susceptibility_to | 3.41963633 |
6 | MP0001835_abnormal_antigen_presentation | 3.38476956 |
7 | MP0003950_abnormal_plasma_membrane | 3.26348407 |
8 | MP0006072_abnormal_retinal_apoptosis | 3.25194413 |
9 | MP0003303_peritoneal_inflammation | 3.09903673 |
10 | MP0005253_abnormal_eye_physiology | 3.07183356 |
11 | MP0003828_pulmonary_edema | 3.04512811 |
12 | MP0002419_abnormal_innate_immunity | 2.95676536 |
13 | MP0004859_abnormal_synaptic_plasticity | 2.93746796 |
14 | MP0004270_analgesia | 2.80490802 |
15 | MP0004885_abnormal_endolymph | 2.76625139 |
16 | MP0009785_altered_susceptibility_to | 2.75807155 |
17 | MP0000569_abnormal_digit_pigmentation | 2.72636465 |
18 | MP0003183_abnormal_peptide_metabolism | 2.66429166 |
19 | MP0001800_abnormal_humoral_immune | 2.52924729 |
20 | MP0005025_abnormal_response_to | 2.45619605 |
21 | MP0001984_abnormal_olfaction | 2.38394168 |
22 | MP0006082_CNS_inflammation | 2.37209539 |
23 | MP0001529_abnormal_vocalization | 2.34578670 |
24 | MP0005000_abnormal_immune_tolerance | 2.33573622 |
25 | MP0005671_abnormal_response_to | 2.31660880 |
26 | MP0003635_abnormal_synaptic_transmissio | 2.28056985 |
27 | MP0000685_abnormal_immune_system | 2.22785284 |
28 | MP0009046_muscle_twitch | 2.22723788 |
29 | MP0002723_abnormal_immune_serum | 2.21381458 |
30 | MP0002272_abnormal_nervous_system | 2.20362229 |
31 | MP0000465_gastrointestinal_hemorrhage | 2.17159025 |
32 | MP0002420_abnormal_adaptive_immunity | 2.15954176 |
33 | MP0003329_amyloid_beta_deposits | 2.15347613 |
34 | MP0002452_abnormal_antigen_presenting | 2.14940305 |
35 | MP0002064_seizures | 2.14587790 |
36 | MP0002229_neurodegeneration | 2.13025689 |
37 | MP0001819_abnormal_immune_cell | 2.12943536 |
38 | MP0003300_gastrointestinal_ulcer | 2.09158647 |
39 | MP0003690_abnormal_glial_cell | 2.09129615 |
40 | MP0005387_immune_system_phenotype | 2.07960308 |
41 | MP0001790_abnormal_immune_system | 2.07960308 |
42 | MP0001486_abnormal_startle_reflex | 2.04177314 |
43 | MP0009745_abnormal_behavioral_response | 2.00762892 |
44 | MP0001533_abnormal_skeleton_physiology | 1.99462192 |
45 | MP0003011_delayed_dark_adaptation | 1.98135321 |
46 | MP0003634_abnormal_glial_cell | 1.94587450 |
47 | MP0003787_abnormal_imprinting | 1.91123288 |
48 | MP0005195_abnormal_posterior_eye | 1.90183205 |
49 | MP0004883_abnormal_blood_vessel | 1.87526431 |
50 | MP0002405_respiratory_system_inflammati | 1.82261973 |
51 | MP0005464_abnormal_platelet_physiology | 1.80806891 |
52 | MP0002148_abnormal_hypersensitivity_rea | 1.76712735 |
53 | MP0002063_abnormal_learning/memory/cond | 1.75150072 |
54 | MP0001661_extended_life_span | 1.73887140 |
55 | MP0000778_abnormal_nervous_system | 1.69937737 |
56 | MP0004043_abnormal_pH_regulation | 1.68794102 |
57 | MP0009780_abnormal_chondrocyte_physiolo | 1.67226638 |
58 | MP0002734_abnormal_mechanical_nocicepti | 1.66054761 |
59 | MP0003632_abnormal_nervous_system | 1.61684074 |
60 | MP0002132_abnormal_respiratory_system | 1.60747439 |
61 | MP0003763_abnormal_thymus_physiology | 1.59084161 |
62 | MP0009764_decreased_sensitivity_to | 1.58415128 |
63 | MP0002090_abnormal_vision | 1.57232889 |
64 | MP0001845_abnormal_inflammatory_respons | 1.56921270 |
65 | MP0000716_abnormal_immune_system | 1.54788159 |
66 | MP0000604_amyloidosis | 1.54554722 |
67 | MP0002398_abnormal_bone_marrow | 1.50321770 |
68 | MP0004484_altered_response_of | 1.49825317 |
69 | MP0001502_abnormal_circadian_rhythm | 1.48622496 |
70 | MP0008877_abnormal_DNA_methylation | 1.47205448 |
71 | MP0003172_abnormal_lysosome_physiology | 1.47192193 |
72 | MP0004924_abnormal_behavior | 1.45571692 |
73 | MP0005386_behavior/neurological_phenoty | 1.45571692 |
74 | MP0002882_abnormal_neuron_morphology | 1.45543896 |
75 | MP0004742_abnormal_vestibular_system | 1.45070297 |
76 | MP0005164_abnormal_response_to | 1.43234414 |
77 | MP0010234_abnormal_vibrissa_follicle | 1.40696018 |
78 | MP0002166_altered_tumor_susceptibility | 1.36573915 |
79 | MP0000689_abnormal_spleen_morphology | 1.35842883 |
80 | MP0001346_abnormal_lacrimal_gland | 1.35772168 |
81 | MP0002572_abnormal_emotion/affect_behav | 1.34728844 |
82 | MP0001177_atelectasis | 1.34079262 |
83 | MP0008004_abnormal_stomach_pH | 1.33884464 |
84 | MP0000013_abnormal_adipose_tissue | 1.33562619 |
85 | MP0002722_abnormal_immune_system | 1.32244148 |
86 | MP0005410_abnormal_fertilization | 1.31876347 |
87 | MP0010155_abnormal_intestine_physiology | 1.31835634 |
88 | MP0005397_hematopoietic_system_phenotyp | 1.31159452 |
89 | MP0001545_abnormal_hematopoietic_system | 1.31159452 |
90 | MP0003656_abnormal_erythrocyte_physiolo | 1.30876358 |
91 | MP0002909_abnormal_adrenal_gland | 1.30768131 |
92 | MP0002067_abnormal_sensory_capabilities | 1.30455592 |
93 | MP0003075_altered_response_to | 1.30290137 |
94 | MP0010386_abnormal_urinary_bladder | 1.28778946 |
95 | MP0001501_abnormal_sleep_pattern | 1.28590681 |
96 | MP0005171_absent_coat_pigmentation | 1.27964382 |
97 | MP0005391_vision/eye_phenotype | 1.27908964 |
98 | MP0010678_abnormal_skin_adnexa | 1.24715118 |
99 | MP0002332_abnormal_exercise_endurance | 1.23890781 |
100 | MP0002638_abnormal_pupillary_reflex | 1.23703578 |
101 | MP0004381_abnormal_hair_follicle | 1.23239362 |
102 | MP0003221_abnormal_cardiomyocyte_apopto | 1.22916636 |
103 | MP0003866_abnormal_defecation | 1.22695540 |
104 | MP0000462_abnormal_digestive_system | 1.22608739 |
105 | MP0003631_nervous_system_phenotype | 1.20431312 |
106 | MP0004130_abnormal_muscle_cell | 1.19946642 |
107 | MP0002752_abnormal_somatic_nervous | 1.19911772 |
108 | MP0005166_decreased_susceptibility_to | 1.19544433 |
109 | MP0008469_abnormal_protein_level | 1.19514549 |
110 | MP0001970_abnormal_pain_threshold | 1.18408496 |
111 | MP0004947_skin_inflammation | 1.18403095 |
112 | MP0008569_lethality_at_weaning | 1.17521357 |
113 | MP0002277_abnormal_respiratory_mucosa | 1.17038473 |
114 | MP0001324_abnormal_eye_pigmentation | 1.16249288 |
115 | MP0005310_abnormal_salivary_gland | 1.13088442 |
116 | MP0002429_abnormal_blood_cell | 1.11773245 |
117 | MP0000955_abnormal_spinal_cord | 1.10970706 |
118 | MP0009278_abnormal_bone_marrow | 1.09838625 |
119 | MP0002998_abnormal_bone_remodeling | 1.08542392 |
120 | MP0000858_altered_metastatic_potential | 1.06746745 |
121 | MP0005423_abnormal_somatic_nervous | 1.05104654 |
122 | MP0003633_abnormal_nervous_system | 1.05089911 |
123 | MP0000703_abnormal_thymus_morphology | 1.04980475 |
124 | MP0001963_abnormal_hearing_physiology | 1.04904877 |
125 | MP0005645_abnormal_hypothalamus_physiol | 1.04657883 |
126 | MP0004782_abnormal_surfactant_physiolog | 1.04187639 |
127 | MP0001440_abnormal_grooming_behavior | 1.04129060 |
128 | MP0008260_abnormal_autophagy | 1.03494403 |
129 | MP0005451_abnormal_body_composition | 1.01959738 |
130 | MP0001905_abnormal_dopamine_level | 1.01599374 |
131 | MP0003045_fibrosis | 1.01313063 |
132 | MP0002066_abnormal_motor_capabilities/c | 1.01014370 |
133 | MP0002733_abnormal_thermal_nociception | 1.00702519 |
134 | MP0006054_spinal_hemorrhage | 1.00011421 |
135 | MP0005075_abnormal_melanosome_morpholog | 0.99893782 |
136 | MP0003121_genomic_imprinting | 0.96668607 |
137 | MP0000427_abnormal_hair_cycle | 0.96544698 |
138 | MP0005646_abnormal_pituitary_gland | 0.96257143 |
139 | MP0003191_abnormal_cellular_cholesterol | 0.94660014 |
140 | MP0004084_abnormal_cardiac_muscle | 0.93046648 |
141 | MP0000015_abnormal_ear_pigmentation | 0.91966561 |
142 | MP0000343_altered_response_to | 0.91816753 |
143 | MP0001968_abnormal_touch/_nociception | 0.90259426 |
144 | MP0001299_abnormal_eye_distance/ | 0.89980220 |
145 | MP0003448_altered_tumor_morphology | 0.89261227 |
146 | MP0009763_increased_sensitivity_to | 0.89111213 |
147 | MP0001851_eye_inflammation | 0.88508030 |
148 | MP0003698_abnormal_male_reproductive | 0.87966048 |
149 | MP0002396_abnormal_hematopoietic_system | 0.87879082 |
150 | MP0000631_abnormal_neuroendocrine_gland | 0.87647357 |
151 | MP0000249_abnormal_blood_vessel | 0.87314689 |
152 | MP0002006_tumorigenesis | 0.84233484 |
153 | MP0001958_emphysema | 0.82223475 |
154 | MP0004510_myositis | 0.82202392 |
155 | MP0005058_abnormal_lysosome_morphology | 0.81599504 |
156 | MP0002152_abnormal_brain_morphology | 0.80805911 |
157 | MP0001485_abnormal_pinna_reflex | 0.76923432 |
158 | MP0002557_abnormal_social/conspecific_i | 0.76917133 |
159 | MP0004811_abnormal_neuron_physiology | 0.75240584 |
160 | MP0002184_abnormal_innervation | 0.73456858 |
161 | MP0002138_abnormal_hepatobiliary_system | 0.72447277 |
162 | MP0005376_homeostasis/metabolism_phenot | 0.71357738 |
163 | MP0003252_abnormal_bile_duct | 0.69379960 |
164 | MP0002822_catalepsy | 0.69185726 |
165 | MP0009765_abnormal_xenobiotic_induced | 0.68686190 |
166 | MP0004036_abnormal_muscle_relaxation | 0.68585609 |
167 | MP0000003_abnormal_adipose_tissue | 0.68141753 |
168 | MP0003091_abnormal_cell_migration | 0.68090143 |
169 | MP0005167_abnormal_blood-brain_barrier | 0.67408875 |
170 | MP0005388_respiratory_system_phenotype | 0.66866743 |
171 | MP0002133_abnormal_respiratory_system | 0.66866743 |
172 | MP0004233_abnormal_muscle_weight | 0.66452009 |
173 | MP0003646_muscle_fatigue | 0.66304197 |
174 | MP0002971_abnormal_brown_adipose | 0.65685160 |
175 | MP0002837_dystrophic_cardiac_calcinosis | 0.63411652 |
176 | MP0005499_abnormal_olfactory_system | 0.62971295 |
177 | MP0005394_taste/olfaction_phenotype | 0.62971295 |
178 | MP0005535_abnormal_body_temperature | 0.62581434 |
179 | MP0005390_skeleton_phenotype | 0.62491949 |
180 | MP0005174_abnormal_tail_pigmentation | 0.61677861 |
181 | MP0008874_decreased_physiological_sensi | 0.59347753 |
182 | MP0001853_heart_inflammation | 0.58084699 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Eczematoid dermatitis (HP:0000976) | 6.13382704 |
2 | Congenital stationary night blindness (HP:0007642) | 5.93778608 |
3 | Recurrent bacterial skin infections (HP:0005406) | 5.92803290 |
4 | Recurrent abscess formation (HP:0002722) | 5.77304713 |
5 | Myositis (HP:0100614) | 5.42163285 |
6 | Optic neuritis (HP:0100653) | 5.26832337 |
7 | Retrobulbar optic neuritis (HP:0100654) | 5.26832337 |
8 | Orchitis (HP:0100796) | 5.26254652 |
9 | Central scotoma (HP:0000603) | 4.91664642 |
10 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.83372644 |
11 | Abnormality of macular pigmentation (HP:0008002) | 4.63840356 |
12 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 4.59120022 |
13 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 4.59120022 |
14 | Abnormality of macrophages (HP:0004311) | 4.48548949 |
15 | Bony spicule pigmentary retinopathy (HP:0007737) | 4.46880131 |
16 | Gastrointestinal infarctions (HP:0005244) | 4.35320968 |
17 | Neurofibrillary tangles (HP:0002185) | 4.31429775 |
18 | Stomatitis (HP:0010280) | 4.23469762 |
19 | Keratoconjunctivitis sicca (HP:0001097) | 4.08718745 |
20 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.98509084 |
21 | Recurrent fungal infections (HP:0002841) | 3.93322934 |
22 | Recurrent skin infections (HP:0001581) | 3.89477685 |
23 | Abolished electroretinogram (ERG) (HP:0000550) | 3.81551699 |
24 | Keratoconjunctivitis (HP:0001096) | 3.79177000 |
25 | T lymphocytopenia (HP:0005403) | 3.75014981 |
26 | Abnormality of the corticospinal tract (HP:0002492) | 3.73224707 |
27 | Dyschromatopsia (HP:0007641) | 3.60152394 |
28 | Cone-rod dystrophy (HP:0000548) | 3.58040241 |
29 | Gingivitis (HP:0000230) | 3.58012368 |
30 | Abnormality of T cell number (HP:0011839) | 3.55798602 |
31 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.55027900 |
32 | Recurrent cutaneous fungal infections (HP:0011370) | 3.55027900 |
33 | Mediastinal lymphadenopathy (HP:0100721) | 3.54656900 |
34 | Choroideremia (HP:0001139) | 3.53843678 |
35 | Scotoma (HP:0000575) | 3.53580540 |
36 | Abnormal rod and cone electroretinograms (HP:0008323) | 3.49581694 |
37 | Spontaneous hematomas (HP:0007420) | 3.46711580 |
38 | Hypochromic microcytic anemia (HP:0004840) | 3.45724030 |
39 | Encephalitis (HP:0002383) | 3.45037907 |
40 | Decreased central vision (HP:0007663) | 3.42543734 |
41 | Gingival bleeding (HP:0000225) | 3.37398677 |
42 | Meningitis (HP:0001287) | 3.33388440 |
43 | Cerebral inclusion bodies (HP:0100314) | 3.31469486 |
44 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.30218723 |
45 | Chest pain (HP:0100749) | 3.28549689 |
46 | Spastic gait (HP:0002064) | 3.24450846 |
47 | Amyloidosis (HP:0011034) | 3.14749790 |
48 | Arterial thrombosis (HP:0004420) | 3.14433130 |
49 | Obstructive lung disease (HP:0006536) | 3.06774017 |
50 | Chronic obstructive pulmonary disease (HP:0006510) | 3.06774017 |
51 | Hemoptysis (HP:0002105) | 3.04345489 |
52 | Pigmentary retinal degeneration (HP:0001146) | 3.00196587 |
53 | Peritonitis (HP:0002586) | 2.99754206 |
54 | Epileptic encephalopathy (HP:0200134) | 2.99476964 |
55 | Supranuclear gaze palsy (HP:0000605) | 2.99264590 |
56 | Urticaria (HP:0001025) | 2.97490896 |
57 | Leukocytosis (HP:0001974) | 2.96888775 |
58 | Vasculitis (HP:0002633) | 2.96582094 |
59 | Sensory axonal neuropathy (HP:0003390) | 2.92531826 |
60 | Ankle clonus (HP:0011448) | 2.83156602 |
61 | Pulmonary infiltrates (HP:0002113) | 2.82847283 |
62 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.82664768 |
63 | Atonic seizures (HP:0010819) | 2.79202935 |
64 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.78315042 |
65 | Chorioretinal atrophy (HP:0000533) | 2.76716815 |
66 | Pulmonary embolism (HP:0002204) | 2.73889770 |
67 | Intention tremor (HP:0002080) | 2.67222137 |
68 | Episodic fever (HP:0001954) | 2.64998361 |
69 | Prolonged bleeding time (HP:0003010) | 2.64350558 |
70 | Volvulus (HP:0002580) | 2.64240123 |
71 | Oligodactyly (hands) (HP:0001180) | 2.62831298 |
72 | Anorexia (HP:0002039) | 2.61762428 |
73 | Dysmetria (HP:0001310) | 2.60786753 |
74 | Epistaxis (HP:0000421) | 2.58623271 |
75 | Abnormality of T cells (HP:0002843) | 2.52977425 |
76 | Macular degeneration (HP:0000608) | 2.50410092 |
77 | Muscle fiber splitting (HP:0003555) | 2.50111440 |
78 | Papillary thyroid carcinoma (HP:0002895) | 2.44887235 |
79 | Attenuation of retinal blood vessels (HP:0007843) | 2.43580358 |
80 | Osteomyelitis (HP:0002754) | 2.43532373 |
81 | Thickened helices (HP:0000391) | 2.43131818 |
82 | Scanning speech (HP:0002168) | 2.40767353 |
83 | Gangrene (HP:0100758) | 2.40620748 |
84 | Keratoconus (HP:0000563) | 2.39291874 |
85 | Increased corneal curvature (HP:0100692) | 2.39291874 |
86 | Vaginal atresia (HP:0000148) | 2.38505028 |
87 | Widely spaced teeth (HP:0000687) | 2.37616842 |
88 | Cellulitis (HP:0100658) | 2.37578360 |
89 | Difficulty running (HP:0009046) | 2.37401723 |
90 | Onion bulb formation (HP:0003383) | 2.37139239 |
91 | Gait imbalance (HP:0002141) | 2.36335329 |
92 | Vertigo (HP:0002321) | 2.35005574 |
93 | Lower limb muscle weakness (HP:0007340) | 2.33656089 |
94 | Gaze-evoked nystagmus (HP:0000640) | 2.29672434 |
95 | Abnormal auditory evoked potentials (HP:0006958) | 2.29659104 |
96 | Genital tract atresia (HP:0001827) | 2.29494758 |
97 | Type II diabetes mellitus (HP:0005978) | 2.29471205 |
98 | Nephrogenic diabetes insipidus (HP:0009806) | 2.28320200 |
99 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.26641805 |
100 | Eosinophilia (HP:0001880) | 2.26245675 |
101 | Retinitis pigmentosa (HP:0000510) | 2.25583244 |
102 | Inflammation of the large intestine (HP:0002037) | 2.24440515 |
103 | Photophobia (HP:0000613) | 2.23656818 |
104 | Congenital primary aphakia (HP:0007707) | 2.23029429 |
105 | Recurrent viral infections (HP:0004429) | 2.22449960 |
106 | Focal motor seizures (HP:0011153) | 2.19674532 |
107 | Clonus (HP:0002169) | 2.17304881 |
108 | Recurrent bronchitis (HP:0002837) | 2.16502746 |
109 | Papilledema (HP:0001085) | 2.16366688 |
110 | Acute hepatic failure (HP:0006554) | 2.15936146 |
111 | Medial flaring of the eyebrow (HP:0010747) | 2.15927412 |
112 | Microcytic anemia (HP:0001935) | 2.15051162 |
113 | Periodontitis (HP:0000704) | 2.14314379 |
114 | Absence seizures (HP:0002121) | 2.13282140 |
115 | Septo-optic dysplasia (HP:0100842) | 2.13126875 |
116 | Hypochromic anemia (HP:0001931) | 2.12545488 |
117 | Abnormality of eosinophils (HP:0001879) | 2.11174839 |
118 | Urinary urgency (HP:0000012) | 2.11148663 |
119 | Granulocytopenia (HP:0001913) | 2.10995163 |
120 | Panhypogammaglobulinemia (HP:0003139) | 2.09656384 |
121 | Truncal ataxia (HP:0002078) | 2.09580807 |
122 | Increased IgE level (HP:0003212) | 2.08805428 |
123 | Abnormality of the pleura (HP:0002103) | 2.08450152 |
124 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.08230537 |
125 | Aqueductal stenosis (HP:0002410) | 2.07831873 |
126 | Progressive cerebellar ataxia (HP:0002073) | 2.07068041 |
127 | Myokymia (HP:0002411) | 2.06896754 |
128 | Retinal dysplasia (HP:0007973) | 2.06559822 |
129 | Abnormality of the endocardium (HP:0004306) | 2.05575867 |
130 | Hemiplegia (HP:0002301) | 2.03689850 |
131 | Thrombophlebitis (HP:0004418) | 2.02506765 |
132 | Abnormality of the peritoneum (HP:0002585) | 2.02502225 |
133 | Sepsis (HP:0100806) | 2.02198655 |
134 | Amaurosis fugax (HP:0100576) | 2.01193344 |
135 | Gastrointestinal inflammation (HP:0004386) | 1.99580470 |
136 | IgM deficiency (HP:0002850) | 1.99153013 |
137 | Polyneuropathy (HP:0001271) | 1.98285070 |
138 | Pendular nystagmus (HP:0012043) | 1.96947530 |
139 | Type II lissencephaly (HP:0007260) | 1.95952299 |
140 | Keratitis (HP:0000491) | 1.94970478 |
141 | Excessive salivation (HP:0003781) | 1.93626494 |
142 | Drooling (HP:0002307) | 1.93626494 |
143 | Blue irides (HP:0000635) | 1.93122873 |
144 | Dialeptic seizures (HP:0011146) | 1.92206424 |
145 | Glomerulopathy (HP:0100820) | 1.91048033 |
146 | Stomach cancer (HP:0012126) | 1.90913869 |
147 | Abnormality of the labia minora (HP:0012880) | 1.90239741 |
148 | Abnormal platelet volume (HP:0011876) | 1.89895972 |
149 | Absent speech (HP:0001344) | 1.89602383 |
150 | Slow saccadic eye movements (HP:0000514) | 1.89599554 |
151 | Abnormality of the salivary glands (HP:0010286) | 1.88205967 |
152 | Epileptiform EEG discharges (HP:0011182) | 1.87900699 |
153 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.87734952 |
154 | Colitis (HP:0002583) | 1.86927862 |
155 | Amyotrophic lateral sclerosis (HP:0007354) | 1.86329839 |
156 | Abnormality of the periventricular white matter (HP:0002518) | 1.85437024 |
157 | EEG with generalized epileptiform discharges (HP:0011198) | 1.84758238 |
158 | Thyroiditis (HP:0100646) | 1.83830771 |
159 | Gastrointestinal stroma tumor (HP:0100723) | 1.83677273 |
160 | Subacute progressive viral hepatitis (HP:0006572) | 1.83079153 |
161 | Specific learning disability (HP:0001328) | 1.82267449 |
162 | Stenosis of the external auditory canal (HP:0000402) | 1.81972647 |
163 | Clumsiness (HP:0002312) | 1.81328259 |
164 | Hematochezia (HP:0002573) | 1.80711800 |
165 | Insidious onset (HP:0003587) | 1.80703335 |
166 | Termporal pattern (HP:0011008) | 1.80703335 |
167 | Akinesia (HP:0002304) | 1.79642636 |
168 | Viral hepatitis (HP:0006562) | 1.79173925 |
169 | Focal seizures (HP:0007359) | 1.78969752 |
170 | Febrile seizures (HP:0002373) | 1.78925646 |
171 | Increased CSF protein (HP:0002922) | 1.77643534 |
172 | Disinhibition (HP:0000734) | 1.76576326 |
173 | Labial hypoplasia (HP:0000066) | 1.76339388 |
174 | Resting tremor (HP:0002322) | 1.75708787 |
175 | Premature loss of primary teeth (HP:0006323) | 1.74645758 |
176 | Progressive visual loss (HP:0000529) | 1.74428588 |
177 | Anteriorly placed anus (HP:0001545) | 1.73333316 |
178 | Toxemia of pregnancy (HP:0100603) | 1.73061124 |
179 | Peripheral hypomyelination (HP:0007182) | 1.71584795 |
180 | Abnormality of T cell physiology (HP:0011840) | 1.71196142 |
181 | Poor coordination (HP:0002370) | 1.70338747 |
182 | Hyporeflexia of lower limbs (HP:0002600) | 1.70300378 |
183 | Progressive inability to walk (HP:0002505) | 1.69833891 |
184 | Postural instability (HP:0002172) | 1.68088520 |
185 | Cerebral hypomyelination (HP:0006808) | 1.67936898 |
186 | Acne (HP:0001061) | 1.67650089 |
187 | Megalencephaly (HP:0001355) | 1.67644538 |
188 | Paresthesia (HP:0003401) | 1.67309694 |
189 | Recurrent pneumonia (HP:0006532) | 1.67002936 |
190 | Chronic otitis media (HP:0000389) | 1.66729985 |
191 | Poor speech (HP:0002465) | 1.66231437 |
192 | Facial diplegia (HP:0001349) | 1.65572299 |
193 | Hypoplastic female external genitalia (HP:0012815) | 1.61540574 |
194 | Severe visual impairment (HP:0001141) | 1.60887369 |
195 | Alacrima (HP:0000522) | 1.60304454 |
196 | Cortical dysplasia (HP:0002539) | 1.59232240 |
197 | Thyroid carcinoma (HP:0002890) | 1.59121889 |
198 | Action tremor (HP:0002345) | 1.57871601 |
Rank | Gene Set | Z-score |
---|---|---|
1 | STK39 | 4.47839065 |
2 | OXSR1 | 3.59810926 |
3 | BLK | 3.23585306 |
4 | MAP3K13 | 2.66459952 |
5 | BCR | 2.59219644 |
6 | MAP2K3 | 2.57407214 |
7 | IRAK4 | 2.55935816 |
8 | PAK6 | 2.49051684 |
9 | TYK2 | 2.43288977 |
10 | PBK | 2.26419601 |
11 | KSR2 | 2.24945159 |
12 | FGFR2 | 2.23125748 |
13 | MAP3K9 | 2.11156625 |
14 | EPHB1 | 2.10937227 |
15 | TXK | 2.05875245 |
16 | GRK6 | 1.98701700 |
17 | PRPF4B | 1.95696899 |
18 | WNK1 | 1.94302778 |
19 | MAP4K1 | 1.92928198 |
20 | PKN1 | 1.91225379 |
21 | WNK4 | 1.83266585 |
22 | MAP3K4 | 1.80981491 |
23 | ZAP70 | 1.75419642 |
24 | EPHA4 | 1.71630641 |
25 | NTRK1 | 1.68586600 |
26 | IKBKE | 1.67884692 |
27 | TNK2 | 1.63026303 |
28 | JAK2 | 1.62891654 |
29 | HCK | 1.60948292 |
30 | JAK1 | 1.60856445 |
31 | FGR | 1.59908003 |
32 | JAK3 | 1.58601444 |
33 | SYK | 1.57951189 |
34 | MET | 1.56381323 |
35 | YES1 | 1.55694151 |
36 | FRK | 1.55080816 |
37 | NEK6 | 1.53943241 |
38 | TAOK3 | 1.53704693 |
39 | PIK3CG | 1.53144761 |
40 | TGFBR2 | 1.52907445 |
41 | SGK223 | 1.52333642 |
42 | SGK494 | 1.52333642 |
43 | BTK | 1.51987671 |
44 | CDK19 | 1.49647364 |
45 | CSNK1A1L | 1.44536427 |
46 | MAP3K14 | 1.39377798 |
47 | INSRR | 1.38522129 |
48 | LYN | 1.37757021 |
49 | KSR1 | 1.34170109 |
50 | MAP3K3 | 1.33232120 |
51 | CAMK2B | 1.32689121 |
52 | CLK1 | 1.30593514 |
53 | CSNK1G3 | 1.26503395 |
54 | TEC | 1.24800108 |
55 | KIT | 1.24360780 |
56 | MST4 | 1.23497034 |
57 | RIPK4 | 1.18656433 |
58 | TAOK1 | 1.18215596 |
59 | CASK | 1.18197569 |
60 | GRK1 | 1.18063457 |
61 | CSNK1G2 | 1.17577821 |
62 | BCKDK | 1.15040208 |
63 | NTRK3 | 1.14712708 |
64 | ACVR1B | 1.14440707 |
65 | CAMK1D | 1.13532156 |
66 | IRAK1 | 1.13356409 |
67 | CAMK1G | 1.13340207 |
68 | MAP3K1 | 1.11984441 |
69 | CAMK2D | 1.11327714 |
70 | MAP3K2 | 1.10619407 |
71 | ICK | 1.08264724 |
72 | TBK1 | 1.04706646 |
73 | MAP3K5 | 1.04084146 |
74 | LCK | 1.03689348 |
75 | PTK2B | 1.03652522 |
76 | CDK5 | 1.01006327 |
77 | TYRO3 | 1.00422799 |
78 | MELK | 0.99016994 |
79 | PDK4 | 0.98309237 |
80 | PDK3 | 0.98309237 |
81 | ROCK2 | 0.97785130 |
82 | MARK3 | 0.96841380 |
83 | OBSCN | 0.96663957 |
84 | CSNK1G1 | 0.93668161 |
85 | NLK | 0.93663540 |
86 | MARK1 | 0.92793296 |
87 | FGFR3 | 0.87348391 |
88 | MATK | 0.84854691 |
89 | WNK3 | 0.83643124 |
90 | PDK2 | 0.83177508 |
91 | UHMK1 | 0.80833680 |
92 | IRAK2 | 0.80242261 |
93 | LIMK1 | 0.77070360 |
94 | CAMKK2 | 0.76947580 |
95 | MAP2K7 | 0.76641135 |
96 | NTRK2 | 0.76511561 |
97 | PDPK1 | 0.75348087 |
98 | ERN1 | 0.75215541 |
99 | PDK1 | 0.74485052 |
100 | ERBB3 | 0.73810383 |
101 | SIK3 | 0.70857113 |
102 | CAMK2A | 0.69652078 |
103 | DYRK1B | 0.69188052 |
104 | PRKCH | 0.67914687 |
105 | MAPK7 | 0.67748605 |
106 | MAPK12 | 0.67110119 |
107 | NEK9 | 0.65591398 |
108 | STK10 | 0.65561099 |
109 | PRKCQ | 0.64825507 |
110 | SGK1 | 0.63309517 |
111 | DAPK2 | 0.63159244 |
112 | MAP3K6 | 0.63075124 |
113 | PRKCE | 0.61172113 |
114 | FYN | 0.61049897 |
115 | PAK3 | 0.60485687 |
116 | LRRK2 | 0.60061224 |
117 | CAMK2G | 0.59439993 |
118 | STK11 | 0.59050627 |
119 | MAP3K7 | 0.58831709 |
120 | GRK5 | 0.58376449 |
121 | BMPR2 | 0.56498908 |
122 | GRK7 | 0.55771449 |
123 | PLK2 | 0.54379406 |
124 | MARK2 | 0.54210393 |
125 | MAPK10 | 0.53269526 |
126 | PRKD3 | 0.53090946 |
127 | PDGFRB | 0.52764925 |
128 | ITK | 0.51256235 |
129 | PIM1 | 0.50900253 |
130 | DYRK1A | 0.50420826 |
131 | RAF1 | 0.50328647 |
132 | FES | 0.50169423 |
133 | CDK14 | 0.50113760 |
134 | MAP3K11 | 0.49386439 |
135 | RET | 0.49123988 |
136 | CSNK1D | 0.47889157 |
137 | CDK6 | 0.47655407 |
138 | EPHA3 | 0.47397439 |
139 | STK38 | 0.47353403 |
140 | SGK2 | 0.47288081 |
141 | EIF2AK3 | 0.47139221 |
142 | PINK1 | 0.46770727 |
143 | MINK1 | 0.46736658 |
144 | CSK | 0.46507463 |
145 | MAP4K2 | 0.46193598 |
146 | EGFR | 0.45674555 |
147 | MAP3K12 | 0.45326053 |
148 | SGK3 | 0.45118060 |
149 | CDK15 | 0.44875255 |
150 | CDK18 | 0.44735912 |
151 | BMPR1B | 0.42955611 |
152 | CSF1R | 0.42541131 |
153 | ARAF | 0.42278469 |
154 | CAMK4 | 0.41853167 |
155 | TRPM7 | 0.41395298 |
156 | AKT3 | 0.40952531 |
157 | MOS | 0.40792547 |
158 | MAPKAPK5 | 0.39910118 |
159 | PNCK | 0.37277027 |
160 | MAP2K4 | 0.37132741 |
161 | PRKAA2 | 0.35167292 |
162 | FER | 0.34861953 |
163 | RPS6KA3 | 0.34681643 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Phototransduction_Homo sapiens_hsa04744 | 4.53436245 |
2 | Leishmaniasis_Homo sapiens_hsa05140 | 3.22455659 |
3 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.95589475 |
4 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.91234057 |
5 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.30339950 |
6 | GABAergic synapse_Homo sapiens_hsa04727 | 2.26509381 |
7 | Morphine addiction_Homo sapiens_hsa05032 | 2.23945218 |
8 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.19681516 |
9 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.15577471 |
10 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.09482374 |
11 | Nicotine addiction_Homo sapiens_hsa05033 | 2.06178027 |
12 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.98897101 |
13 | Malaria_Homo sapiens_hsa05144 | 1.91220366 |
14 | Legionellosis_Homo sapiens_hsa05134 | 1.88408655 |
15 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.83789838 |
16 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.81959195 |
17 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.80224661 |
18 | Circadian entrainment_Homo sapiens_hsa04713 | 1.76746866 |
19 | Allograft rejection_Homo sapiens_hsa05330 | 1.72192411 |
20 | Olfactory transduction_Homo sapiens_hsa04740 | 1.71320800 |
21 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.69346136 |
22 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.66479193 |
23 | Measles_Homo sapiens_hsa05162 | 1.64361216 |
24 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.60276486 |
25 | Renin secretion_Homo sapiens_hsa04924 | 1.59124614 |
26 | Salivary secretion_Homo sapiens_hsa04970 | 1.57321189 |
27 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.55600974 |
28 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.54012810 |
29 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.50636148 |
30 | Long-term potentiation_Homo sapiens_hsa04720 | 1.46249376 |
31 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.44630891 |
32 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.44309168 |
33 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.44045693 |
34 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.42695260 |
35 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.42449302 |
36 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.41238934 |
37 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.41156481 |
38 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.37817562 |
39 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.37204770 |
40 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.37080544 |
41 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.36739245 |
42 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.33464882 |
43 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.32799142 |
44 | Long-term depression_Homo sapiens_hsa04730 | 1.32361293 |
45 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.31960602 |
46 | Insulin secretion_Homo sapiens_hsa04911 | 1.31344559 |
47 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.29152089 |
48 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.29069112 |
49 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.28749697 |
50 | Platelet activation_Homo sapiens_hsa04611 | 1.27974421 |
51 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.27531981 |
52 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.25330327 |
53 | Influenza A_Homo sapiens_hsa05164 | 1.25191306 |
54 | Cocaine addiction_Homo sapiens_hsa05030 | 1.20852372 |
55 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.20770486 |
56 | Alcoholism_Homo sapiens_hsa05034 | 1.20503201 |
57 | Pertussis_Homo sapiens_hsa05133 | 1.19282195 |
58 | Axon guidance_Homo sapiens_hsa04360 | 1.18736210 |
59 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.18610421 |
60 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.18380065 |
61 | Viral myocarditis_Homo sapiens_hsa05416 | 1.16196067 |
62 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.16156620 |
63 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.14607673 |
64 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.12993629 |
65 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.11337831 |
66 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.09917739 |
67 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.09847359 |
68 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.09473025 |
69 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.06966977 |
70 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.02188074 |
71 | Endocytosis_Homo sapiens_hsa04144 | 1.01999055 |
72 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.01931541 |
73 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.00355636 |
74 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.00319966 |
75 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.99835201 |
76 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.98172166 |
77 | Mineral absorption_Homo sapiens_hsa04978 | 0.98162491 |
78 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.97882517 |
79 | Taste transduction_Homo sapiens_hsa04742 | 0.97026163 |
80 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.95976766 |
81 | Hepatitis B_Homo sapiens_hsa05161 | 0.95234770 |
82 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.94800687 |
83 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.93970166 |
84 | Hepatitis C_Homo sapiens_hsa05160 | 0.93840744 |
85 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.93193135 |
86 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.91129705 |
87 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.89855928 |
88 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.89643715 |
89 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.88992733 |
90 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.88682572 |
91 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.87751771 |
92 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.86679611 |
93 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.86221056 |
94 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.86067941 |
95 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.85778330 |
96 | Asthma_Homo sapiens_hsa05310 | 0.85481348 |
97 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.84704954 |
98 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.83754253 |
99 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.83683235 |
100 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.82448535 |
101 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.80493237 |
102 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.80320000 |
103 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.80265004 |
104 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.79102648 |
105 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.78973774 |
106 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.78195930 |
107 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.78183311 |
108 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.77474875 |
109 | Circadian rhythm_Homo sapiens_hsa04710 | 0.76385814 |
110 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.76187708 |
111 | Lysosome_Homo sapiens_hsa04142 | 0.75387893 |
112 | Amoebiasis_Homo sapiens_hsa05146 | 0.72015182 |
113 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.70943931 |
114 | Tight junction_Homo sapiens_hsa04530 | 0.70008951 |
115 | Gap junction_Homo sapiens_hsa04540 | 0.69070330 |
116 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.67666144 |
117 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.67637220 |
118 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.67334858 |
119 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.67240935 |
120 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.66890659 |
121 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.66819785 |
122 | Phagosome_Homo sapiens_hsa04145 | 0.66469537 |
123 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.65693486 |
124 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.64474776 |
125 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.63384999 |
126 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.62777216 |
127 | Apoptosis_Homo sapiens_hsa04210 | 0.62008891 |
128 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.61213416 |
129 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.59542785 |
130 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.58380748 |
131 | Melanogenesis_Homo sapiens_hsa04916 | 0.57917088 |
132 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.56691214 |
133 | Endometrial cancer_Homo sapiens_hsa05213 | 0.55922384 |
134 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.53722708 |
135 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.52316658 |
136 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.51941489 |
137 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.50090806 |
138 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.49743357 |
139 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.48998122 |
140 | Salmonella infection_Homo sapiens_hsa05132 | 0.48002059 |
141 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.46775831 |
142 | Insulin resistance_Homo sapiens_hsa04931 | 0.46253086 |
143 | Glioma_Homo sapiens_hsa05214 | 0.44382510 |
144 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.44200389 |
145 | Colorectal cancer_Homo sapiens_hsa05210 | 0.43645262 |
146 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.43331655 |
147 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.41324118 |
148 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.40777868 |
149 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.38611044 |
150 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.38586242 |
151 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.38314417 |
152 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.36546855 |
153 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.36162234 |
154 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.35764534 |
155 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.35733970 |
156 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.35095888 |
157 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.35000827 |
158 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.34800405 |
159 | Shigellosis_Homo sapiens_hsa05131 | 0.34671334 |
160 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.34426531 |
161 | Tuberculosis_Homo sapiens_hsa05152 | 0.33536780 |
162 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.33526956 |